Teva Pharmaceutical Industries Limited (TEVA) Earnings
|
Expand Research on TEVA
Next EPS Date | 5/8/24 | EPS Growth Rate | +30.0% |
---|---|---|---|
Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +0.8% |
Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/8/24 | Q124 | N/A | $0.52 | N/A | N/A | $3.73B | N/A | N/A | N/A | ||
5/10/23 | Q123 | $0.40 | $0.55 | -$0.15 | $3.7B | $3.61B | = | Details | |||
8/3/17 | Q217 | $1.02 | $1.12 | -$0.10 | $5.7B | $5.76B | = | Details | |||
10/27/21 | Q321 | $0.59 | $0.65 | -$0.06 | $3.9B | $4.03B | = | Details | |||
11/2/17 | Q317 | $1.00 | $1.04 | -$0.04 | $5.61B | $5.62B | = | Details | |||
2/8/11 | Q410 | $1.25 | $1.28 | -$0.03 | $4.42B | $4.64B | N/A | Details | |||
11/3/22 | Q322 | $0.59 | $0.62 | -$0.03 | $3.6B | $3.85B | Details | ||||
2/11/16 | Q415 | $1.28 | $1.29 | -$0.01 | $4.88B | $4.83B | = | Details |